Is Buying VG LIFE SCIENCES INC (OTCMKTS:VGLS), Having Lower Short Interest a Winning Strategy?

June 14, 2018 - By Marguerite Chambers

VG Life Sciences Inc. (OTCMKTS:VGLS) Logo

The stock of VG LIFE SCIENCES INC (OTCMKTS:VGLS) registered a decrease of 28.83% in short interest. VGLS’s total short interest was 31,600 shares in June as published by FINRA. Its down 28.83% from 44,400 shares, reported previously. With 5,400 shares average volume, it will take short sellers 6 days to cover their VGLS’s short positions.

It closed at $0.0087 lastly. It is down 0.00% since June 14, 2017 and is . It has underperformed by 12.57% the S&P500.

VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. The company has market cap of $976,870. It offers VG1177, a solution that deploys a synthesized peptide, which uses its superior binding abilities to eliminate the unwanted Class II-associated invariant chain peptide that is displayed on specific B cells that leads to chronic inflammation. It currently has negative earnings. The firm also provides metabolic disruption technology (MDT) compounds impede tumor cells that sensitize cancer cells to treatment by disrupting the metabolic strategies those cells use to survive; and Hydroxychloroquine, a MDT compound that can be used in combination with other cancer drugs for treating drug-resistant cancers.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.